185 related articles for article (PubMed ID: 30555261)
1. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.
Bernhardt D; Aufderstrasse S; König L; Adeberg S; Bozorgmehr F; Christopoulos P; Shafie RAE; Hörner-Rieber J; Kappes J; Thomas M; Herth F; Steins M; Debus J; Rieken S
Cancer Manag Res; 2018; 10():6563-6569. PubMed ID: 30555261
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy.
Fink CA; Weykamp F; Adeberg S; Bozorgmehr F; Christopoulos P; Lang K; König L; Hörner-Rieber J; Thomas M; Steins M; El-Shafie RA; Rieken S; Bernhardt D; Debus J
Clin Transl Radiat Oncol; 2023 Sep; 42():100665. PubMed ID: 37564923
[TBL] [Abstract][Full Text] [Related]
3. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
4. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
5. Combining
Lin X; Xiao Z; Hu Y; Zhang X; Fan W
Front Pharmacol; 2020; 11():592768. PubMed ID: 33192532
[No Abstract] [Full Text] [Related]
6. Serum lactate dehydrogenase predicts brain metastasis and survival in limited-stage small cell lung cancer patients treated with thoracic radiotherapy and prophylactic cranial irradiation.
Liu J; Wu D; Shen B; Chen M; Zhou X; Zhang P; Qiu G; Ji Y; Du X; Yang Y
Strahlenther Onkol; 2022 Dec; 198(12):1094-1104. PubMed ID: 35857072
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
[TBL] [Abstract][Full Text] [Related]
9. Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
Galvano A; Peri M; Guarini AA; Castiglia M; Grassadonia A; De Tursi M; Irtelli L; Rizzo S; Bertani A; Gristina V; Barraco N; Russo A; Natoli C; Bazan V
Ther Adv Med Oncol; 2020; 12():1758835920942378. PubMed ID: 32849916
[TBL] [Abstract][Full Text] [Related]
10. Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients.
Cao S; Jin S; Shen J; Cao J; Zhang H; Meng Q; Wang C; Zhang A; Zhang P; Yu Y
Oncotarget; 2017 Jan; 8(5):8657-8669. PubMed ID: 28055965
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy.
Guo G; Chen X; Cai X; Chen Y; Wang H; Fan L; Bai L; Qiu H; Zhang B
Transl Cancer Res; 2019 Aug; 8(4):1137-1147. PubMed ID: 35116856
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy.
Sung M; Jang WS; Kim HR; Park JA; Lim SM; Kim HR; Cho BC; Park YR; Hong MH
Transl Lung Cancer Res; 2023 Jul; 12(7):1506-1516. PubMed ID: 37577328
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
14. Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer.
Wang H; Shan D; Dong Y; Yang X; Zhang L; Yu Z
Oncol Lett; 2021 Jan; 21(1):73. PubMed ID: 33365084
[TBL] [Abstract][Full Text] [Related]
15. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
Sert F; Cosgun G; Yalman D; Ozkok S
Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.
Lee JM; Lee HS; Hyun JJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD
World J Gastrointest Oncol; 2016 Jul; 8(7):555-62. PubMed ID: 27559435
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer.
Drpa G; Sutic M; Baranasic J; Jakopovic M; Samarzija M; Kukulj S; Knezevic J
Radiol Oncol; 2020 Sep; 54(4):437-446. PubMed ID: 32960780
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.
Liu J; Wang Z; Liu G; Liu Z; Lu H; Ji S
Ann Med; 2023; 55(2):2242254. PubMed ID: 37552770
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
